Why Up to Half of Transferred Fat Does Not Survive a BBL, and What Actually Determines Graft Take

Patients researching a Brazilian Butt Lift eventually run into a number that surprises them: surgeons commonly quote fat survival rates of roughly 50 to 80 percent, with some published series reporting retention below that range. In plain terms, a meaningful fraction of the fat injected on the day of surgery is expected to be reabsorbed by the body within the first three to six months. This is not a complication. It is the baseline biology of fat grafting, and understanding the mechanism helps patients evaluate what surgeons tell them and why results are not finalized at the first postoperative photo.

Fat is a living graft, not a filler. A transferred fat cell, called an adipocyte, is tissue that must survive relocation. Unlike hyaluronic acid filler, which is an inert gel, grafted fat has to reestablish a blood supply in its new location or it dies. The survival process happens in three overlapping phases. In the first two to four days, fat cells survive by plasmatic imbibition, essentially soaking up oxygen and nutrients from the surrounding fluid, because they have no blood vessels of their own yet. Between roughly days three and seven, inosculation begins: small blood vessels in the recipient tissue connect with vessel remnants in the graft. Finally, over weeks, neovascularization builds new capillary networks into the graft. Fat that sits too far from a capillary during this window, generally more than about 1.5 to 2 millimeters, tends to undergo necrosis and reabsorption.

This distance limit explains one of the most important technical principles in BBL surgery: fat must be injected in thin, dispersed threads across many passes, not deposited in large boluses. A big pool of fat has a core that no capillary can reach in time. That core dies, and the body either reabsorbs it or walls it off as an oil cyst or an area of calcified fat necrosis, which can feel like a firm lump months later. Surgeons who describe injecting during withdrawal of the cannula, in multiple tunnels and layers within the subcutaneous plane, are describing the geometry that keeps fat close to blood supply. Since 2018, safety guidance has also directed injection into subcutaneous fat only, not muscle, which happens to align with graft biology as well as with the prevention of fat embolism.

Harvest technique matters before injection ever begins. Fat cells are mechanically fragile. High suction pressure during liposuction can rupture adipocytes before they are ever transferred, which is why many surgeons use lower vacuum settings for the portion of fat intended for grafting. Processing matters too. Harvested fat is a mix of viable fat cells, ruptured cells, oil, blood, and tumescent fluid. Injecting that mixture unfiltered means part of the measured volume is not living tissue at all, which inflates the day-one appearance and the eventual percentage lost. Common processing methods, including decanting, centrifugation, and closed washing or filtration systems, all aim to concentrate viable adipocytes. No single method has been proven definitively superior in high-quality comparative trials, but the shared goal is the same: inject living cells, not debris.

Patient factors set the ceiling. Recipient site blood supply, overall metabolic health, nicotine exposure, and postoperative behavior all influence retention. Nicotine constricts small vessels precisely when the graft depends on them, which is why smoking and vaping cessation before and after surgery is a standard instruction. Significant weight loss after surgery shrinks grafted fat along with native fat, because surviving grafted adipocytes behave like the fat from their donor site. This is also the honest explanation behind the popular claim that BBL results are permanent: the surviving cells are permanent residents, but their size still tracks with body weight.

What about sitting restrictions? The common instruction to avoid direct sitting for roughly two weeks, often using an offloading pillow afterward, is grounded in the same vascular logic. Sustained pressure on newly grafted tissue can compress the fragile capillary connections forming during inosculation. The exact duration is based on surgical judgment rather than randomized trial data, and protocols vary between one and eight weeks, but the mechanism being protected is real.

The practical takeaway is that final volume cannot be judged early. Swelling exaggerates size in the first weeks, then reabsorption of nonviable fat reduces it, with most surgeons considering results stable around three to six months. A reasonable question for any consultation is not whether fat survival is guaranteed, but how the surgeon harvests, processes, and distributes fat to work with the biology rather than against it. Retention percentages quoted without reference to technique, injection plane, and patient factors are marketing numbers, not clinical ones.

Related reading: How Much Fat Does a BBL Need? Donor Sites, Volume, and the Limits of Transfer.